Clinical trial

Long-term Safety and Efficacy Study of Teduglutide in Pediatric Participants…

NCT02954458 · Shire, Industry · Completed

Key facts

NCT number NCT02954458
Title Long-term Safety and Efficacy Study of Teduglutide in Pediatric Participants With Short Bowel Syndrome (SBS)
Official title A Prospective, Open-label, Long-term Safety and Efficacy Study of Teduglutide in Pediatric Patients With Short Bowel Syndrome Who Completed TED-C14-006 or SHP633-301
Lead sponsor Shire, Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Short Bowel Syndrome
Intervention type Device, Drug, Other
Interventions TED, SOC, Syringe, Needle
Enrollment 61
Start date Jan 9, 2017
Primary completion Nov 5, 2020
Completion Nov 5, 2020
First posted Nov 3, 2016
Last update posted Mar 28, 2025
Countries Belgium, Canada, Finland, Italy, United Kingdom, United States

At a glance

  • 10–99 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies